These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Author: Leuenberger P, Sauty A, Rochat T.
    Journal: Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662.
    Abstract:
    Omalizumab is a humanized monoclonal antibody that is directed against IgE. It has been shown to improve the control of severe allergic asthma in adults and adolescents. Candidates to the treatment are asthmatic patients with positive prick tests and/or in vitro markers of allergy, altered pulmonary function tests, and persistent daytime or nocturnal symptoms despite appropriate treatment with inhaled corticosteroids and long-acting beta-2-agonists.
    [Abstract] [Full Text] [Related] [New Search]